Abstract
Fluorinated 3,4-dihydro-2H-1,4-benzoxazine derivatives possessing both thrombin inhibitory and glycoprotein IIb/IIIa receptor antagonistic activities were prepared as potential dual antithrombotic compounds. Fluorine scan (3-fluorobenzyl, 4-fluorobenzyl, 3,4-difluorobenzyl and 3,5-difluorobenzyl substituted compounds) was performed in order to obtain 6-(carboxymethyl)(3,4-difluorobenzyl)amino compound (9i) as the most potent compound with balanced dual activity (K(i(Thr))=0.33±0.07μM, IC(50(GP IIb/IIIa))=1.1±0.6μM).
Copyright © 2012 Elsevier Masson SAS. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Benzoxazines / chemistry*
-
Halogenation
-
Hemostatics / antagonists & inhibitors*
-
Hemostatics / metabolism
-
Humans
-
Models, Molecular
-
Molecular Structure
-
Platelet Aggregation / drug effects*
-
Platelet Aggregation Inhibitors / chemistry*
-
Platelet Aggregation Inhibitors / pharmacology*
-
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
-
Platelet Glycoprotein GPIIb-IIIa Complex / metabolism
-
Structure-Activity Relationship
-
Thrombin / antagonists & inhibitors*
-
Thrombin / metabolism
Substances
-
Benzoxazines
-
Hemostatics
-
Platelet Aggregation Inhibitors
-
Platelet Glycoprotein GPIIb-IIIa Complex
-
Thrombin